Fiserv, Inc. FISV

Key data

The business

Fiserv sells the plumbing that moves money, in three parts. Acceptance is Clover, the cloud register a coffee shop or restaurant taps to take a card, plus Carat for large enterprises; this is the growth engine and the reason the multiple was once high. Fintech is the core banking software small and mid-sized banks run their deposits and loans on, a system of record they almost never rip out. Payments is card processing, the debit networks, card issuing and bill pay. The company earns a sliver of nearly every swipe, and the moat is switching costs: a bank does not swap its ledger and a merchant does not casually replace the box running the store. Recurring, transaction-based revenue is the whole model, which is why a single quarter of shrinkage frightened the market so badly.

The numbers

The sequence is the story: five years of steady compounding, then a stall.

Reported revenue fell 4.1% year over year in Q2 2026, the first decline after years of mid-single-digit growth, and net income dropped 39%. Adjusted earnings fell 25% and missed at $1.84 against $1.91 expected; Q1 had beaten at $1.79 versus $1.57 and Q2 handed it back. The company reports an organic growth figure separately in its release that this data does not carry, so read the decline as reported, not certainly organic. Either way, the direction turned.

Across those years revenue compounded 6.1% a year, but diluted earnings per share compounded 17.6% and free cash flow per share 17.4%. The gap is margin plus a share count cut 15%. That machine only works if revenue keeps climbing, and it just stopped.

They spent roughly $22B retiring stock over five years, $11.7B of it in 2024 and 2025 at $156 to $167, and the stock is now $53. The market is pricing a permanently lower earnings base. The question this memo puts is whether 6.9x adjusted earnings already assumes the decline is forever; the print that settles it is organic revenue growth turning positive again.

Management

The executive departures flagged a few weeks back have since settled into a completed transition rather than deepened: Georgakopoulos, elevated from co-president, now holds the top job, while the former CFO and COO seats turned over. The outgoing chief executive's 2025 package reached $70 million, about 2% of profit, which is a lot. Against that churn the insiders bought: ten open-market purchases totaling $4.5 million and zero sells over twelve months, into a collapsing stock, with Todd putting in $1.06 million and Fritz twice. Buybacks were aggressive and badly timed. The buying, small in dollars but one-directional, is the tell worth weighing.

How it fails or surprises you

The stall goes structural. Reported revenue fell 4.1% and net income 39% in Q2 2026. If Clover growth is rolling over or merchants are drifting to Square and Toast, the base is permanently lower. Two more negative organic prints and 6.9x is not cheap, it is fair for a shrinking business.

Profit is cracking faster than sales (the disconfirming fact). Adjusted earnings fell 25% and missed while revenue fell only 4%. That gap says margin, not just volume, is under pressure, which the "top-line stumble" read does not explain. If margin keeps compressing while buybacks continue, the cash the whole case rests on erodes from both ends.

The cash machine re-rates (right tail). At $53 the stock yields about 14% on free cash flow, and the same $5B annual buyback now retires three times the shares it did at $167. If revenue merely steadies, a ledger-embedded cash generator does not stay at seven times earnings. The print: two quarters of flat-to-positive organic growth.

Closing thoughts

This is an uncertainty a named print resolves, not an exposure and not a fully priced consensus. The market pays 6.9x adjusted earnings and a 14% cash yield as if the decline is permanent, and one quarter is a data point, not a trend. The fatter tail, on judgment rather than arithmetic, is downside: a leveraged rollup with tangible book underwater and net debt near four times cash earnings has less room to absorb a real demand loss than the yield suggests. What is at risk if the stall is genuine is not failure but years of dead money; what the upside is worth if revenue steadies is a large re-rate off a washed-out multiple.

The bet is still that Fiserv keeps running the plumbing behind card payments and bank software, and that Clover keeps growing, that the stall is a stumble and not the end. What breaks it is two more quarters of shrinking revenue with margin following it down. The one pair of numbers that tells you first is organic revenue growth and adjusted operating margin in the next release. It is priced for the story to be over. It is not over yet, but it has to stop getting worse.